Direct Sequencing of Antibodies of the Influenza Immune Response

Information

  • Research Project
  • 9692298
  • ApplicationId
    9692298
  • Core Project Number
    R43IP001085
  • Full Project Number
    6R43IP001085-01M002
  • Serial Number
    001085
  • FOA Number
    PA-16-302
  • Sub Project Id
  • Project Start Date
    9/1/2017 - 6 years ago
  • Project End Date
    3/31/2019 - 5 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/2017 - 6 years ago
  • Budget End Date
    3/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
    M002
  • Award Notice Date
    4/23/2018 - 6 years ago

Direct Sequencing of Antibodies of the Influenza Immune Response

IC Name
National Center for Immunization and Respiratory Diseases (NCIRD)
  • Activity
    R43
  • Administering IC
    IP
  • Application Type
    6
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    225000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MAPP BIOPHARMACEUTICAL, INC.
  • Organization Department
  • Organization DUNS
    137551797
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921212740
  • Organization District
    UNITED STATES